Cardiovascular diseases in European ethnic minorities: Beyond the traditional cardiovascular risk factors
View abstract on PubMed
Summary
This summary is machine-generated.Cardiovascular disease (CVD) burden varies significantly among European ethnic minorities. Addressing social determinants of health and promoting social justice are crucial for improving CVD prevention and treatment outcomes in these vulnerable populations.
Area Of Science
- Public Health
- Epidemiology
- Sociology
Background
- Cardiovascular disease (CVD) presents a significant health burden in European ethnic minorities, with disparities often overlooked.
- Existing research highlights variations in CVD prevalence not only between countries but also within nations across different social strata and ethnic groups.
Discussion
- A holistic approach to CVD management is essential, integrating social determinants of health (SDs) that impact disease burden, treatment, and prognosis.
- The specific relevance of identified SDs for ethnic minority health, including the role of religion, requires further in-depth investigation.
- Adolescents, particularly second-generation immigrants, represent a vulnerable group requiring targeted health interventions and community integration efforts.
Key Insights
- Social determinants of health significantly influence cardiovascular disease risk and outcomes in ethnic minority populations.
- Religion emerges as a potentially important, yet understudied, social determinant affecting cardiovascular health in these groups.
- Adolescent ethnic minorities face unique challenges, necessitating a focus on their physical and mental well-being as a matter of social justice.
Outlook
- Future research should prioritize defining and addressing the unique social determinants of CVD in diverse European ethnic minority groups.
- Policy and healthcare strategies must adopt a culturally sensitive, holistic approach to mitigate CVD disparities.
- Integrating health initiatives with social justice goals is paramount for safeguarding the long-term health of ethnic minority populations.
Related Concept Videos
A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

